Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancers|December 11, 2022
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia CellsIpek Bulut, Adam Lee, Buse Cevatemre, et al.
Dalton Transactions (Cambridge, England : 2003)|December 8, 2020
Cu(ii) and V(iv)O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)-l-alanines reveal promising anticancer therapeutic potentialNádia Ribeiro, Ipek Bulut, Buse Cevatemre, et al.
Dalton Transactions (Cambridge, England : 2003)|May 17, 2024
Enhanced selectivity towards melanoma cells with zinc(II)-Schiff bases containing imidazole derivativesLeonor Côrte-Real, Baris Sergi, Busra Yildirim, et al.
Dalton Transactions (Cambridge, England : 2003)|May 25, 2019
New ternary iron(iii) aminobisphenolate hydroxyquinoline complexes as potential therapeutic agentsCristina P Matos, Yasemin Yildizhan, Zelal Adiguzel, et al.
Journal of Inorganic Biochemistry|August 8, 2022
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexesNádia Ribeiro, Ipek Bulut, Vivien Pósa, et al.
Molecular Human Reproduction|February 27, 2026
Endometriomas are heterogeneous for functional FSH receptor expression and steroidogenic functionCan Benlioglu, Yashar Esmaeilian, Sevgi Yusufoglu, et al.
Frontiers in Chemistry|April 7, 2023
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexesNádia Ribeiro, Ipek Bulut, Baris Sergi, et al.
Data in Brief|November 5, 2019
Experimental data on novel Fe(III)-complexes containing phenanthroline derivatives for their anticancer propertiesCristina P Matos, Zelal Adiguzel, Yasemin Yildizhan, et al.
European Journal of Medicinal Chemistry|May 28, 2019
May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?Cristina P Matos, Zelal Adiguzel, Yasemin Yildizhan, et al.
Pageof 5